A renowned Israeli TV journalist who lost his ability to speak clearly because of ALS is returning to the air using ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.

A study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

Denali Therapeutics Inc. DNLI announced disappointing top-line results from an analysis of Regimen G of the phase II/III ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

Neurosense entered a binding term sheet with a global pharmaceutical company to advance development and commercialization of ...

Denali's DNL343 missed efficacy goals in the HEALEY ALS trial but was well-tolerated. Analysts await detailed biomarker data ...

A clinical trial evaluating the drug fosigotifator in patients with amyotrophic lateral sclerosis has failed to meet its primary endpoint, according to topline results from the Healey ALS platform ...

a Phase 2 global study evaluating tibulizumab for the treatment of systemic sclerosis (SSc) in adults.

SOUTH KINGSTOWN, R.I. (WJAR) — A Narragansett woman is getting help from her community and church congregation just months after being diagnosed with amyotrophic lateral sclerosis. After dealing ...